Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Eunyoung Lee"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Article
Clinical Study
The Association of Overt and Subclinical Hyperthyroidism with the Risk of Cardiovascular Events and Cardiovascular Mortality: Meta-Analysis and Systematic Review of Cohort Studies
Seo Young Sohn, Eunyoung Lee, Min Kyung Lee, Jae Hyuk Lee
Endocrinol Metab. 2020;35(4):786-800.   Published online November 25, 2020
DOI: https://doi.org/10.3803/EnM.2020.728
  • 6,107 View
  • 288 Download
  • 20 Web of Science
  • 24 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Whether hyperthyroidism is an independent risk factor for cardiovascular events remains controversial. We aimed to evaluate the association of overt and subclinical hyperthyroidism with the risk of ischemic heart disease (IHD), stroke, heart failure, and cardiovascular mortality.
Methods
Studies regarding the association between hyperthyroidism and cardiovascular events were searched on PubMed and Embase databases. The cardiovascular disease (CVD) risk was classified as high and low, based on pre-existing diseases, including history of coronary, cerebral, or peripheral artery disease; heart failure; atrial fibrillation; diabetes mellitus; or chronic kidney disease.
Results
Thirty-seven cohort studies were included in this meta-analysis. The pooled hazard ratio for subjects with overt hyperthyroidism compared with the control group was 1.11 (95% confidence interval [CI], 1.03 to 1.19) for IHD, 1.35 (95% CI, 1.03 to 1.75) for stroke, and 1.20 (95% CI, 1.00 to 1.46) for cardiovascular mortality. For subjects with subclinical hyperthyroidism, the pooled hazard ratio was 1.24 (95% CI, 1.07 to 1.45) for IHD, when compared with the control group. Subgroup analysis by CVD risk showed that the risk of stroke in overt hyperthyroidism was increased in the low CVD risk group; however, these association was not observed in the high CVD risk group. Similarly, the risk of IHD in subjects with subclinical hyperthyroidism was significantly increased in the low CVD risk group.
Conclusion
Overt hyperthyroidism is associated with increased risk of IHD, stroke, and cardiovascular mortality, and subclinical hyperthyroidism is associated with increased risk of IHD. These associations were particularly observed in the low risk CVD group without underlying CVD.

Citations

Citations to this article as recorded by  
  • Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012
    Xiaowen Zhang, Yong Wang, Hongwei Wang, Xinlin Zhang
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e657.     CrossRef
  • Adequacy of thyroid hormone replacement for people with hypothyroidism in real‐world settings: A systematic review and meta‐analysis of observational studies
    Agathoklis Efthymiadis, Matthew Henry, Dimitrios Spinos, Marianthi Bourlaki, Alexandros Tsikopoulos, Angeliki Bourazana, Anastasios Bastounis, Konstantinos Tsikopoulos
    Clinical Endocrinology.2024; 100(5): 488.     CrossRef
  • Thyroid Disorders and Peripheral Arterial Disease
    Katica Bajuk Studen, Simona Gaberscek, Katja Zaletel, Ales Blinc, Miso Sabovic, Gerit-Holger Schernthaner, Panagiotis Anagnostis, Pier Luigi Antignani, Mojca Jensterle, Dimitri P Mikhailidis, Pavel Poredos
    Current Vascular Pharmacology.2024; 22(1): 36.     CrossRef
  • Hormonal influences on cerebral aneurysms: unraveling the complex connections
    Zahra Hasanpour Segherlou, Mahdieh Shakeri, Armin Khavandegar, Sara Stephenson, Kimberly Ciccone, Forough Masheghati, Mohammad Reza Hosseini Siyanaki, Mac Lyerly, Brandon Lucke-Wold
    Expert Review of Endocrinology & Metabolism.2024;[Epub]     CrossRef
  • Pulmonary Embolism in Patients Admitted With Takotsubo Cardiomyopathy: Prevalence and Associated In-Hospital Adverse Events
    Omar Elkattawy, Antonia Sames, Sruthi Kunamneni , Riya Sutariya , Mohamed Ismail, Omar Mohamed , Thomas J Lee, Jahanzeb Javed, Sherif Elkattawy, Afif Hossain, Fayez Shamoon
    Cureus.2024;[Epub]     CrossRef
  • Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation
    Pang-Shuo Huang, Jen-Fang Cheng, Jien-Jiun Chen, Yi-Chih Wang, Juey-Jen Hwang, Cho-Kai Wu, Chia-Ti Tsai
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): 92.     CrossRef
  • Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)
    I. E. Chazova, N. M. Chikhladze, N. V. Blinova, Zh. E. Belaya, N. M. Danilov, E. M. Elfimova, A. Yu. Litvin, L. Ya. Rozhinskaya, N. Yu. Sviridenko, M. Yu. Shvetsov, V. A. Azizov, E. A. Grigorenko, N. P. Mit’kovskaja, I. I. Mustafaev, A. G. Polupanov, A. S
    Eurasian heart journal.2023; (1): 6.     CrossRef
  • Sympathetic Activation Promotes Cardiomyocyte Apoptosis in a Rabbit Susceptibility Model of Hyperthyroidism-Induced Atrial Fibrillation via the p38 MAPK Signaling Pathway
    Jialin Zheng, Shijian Zhao, Qishi Yang, Yantao Wei, Jianmei Li, Tao Guo
    Critical Reviews in Eukaryotic Gene Expression.2023; 33(5): 17.     CrossRef
  • Cardiovascular outcomes in subclinical thyroid disease: an update
    Matthew D. Ettleson
    Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(5): 218.     CrossRef
  • Lower free triiodothyronine levels are associated with higher all-cause and cardiovascular mortality in people with diabetes-NHANES 2007–2012
    Chang Liu, Zhong Xin, Lin Hua
    Diabetes Research and Clinical Practice.2023; 202: 110811.     CrossRef
  • Hyperthyroidism
    Sun Y. Lee, Elizabeth N. Pearce
    JAMA.2023; 330(15): 1472.     CrossRef
  • Is Thyroid Dysfunction Associated with Unruptured Intracranial Aneurysms? A Population-Based, Nested Case–Control Study from Korea
    Hyeree Park, Sun Wook Cho, Sung Ho Lee, Kangmin Kim, Hyun-Seung Kang, Jeong Eun Kim, Aesun Shin, Won-Sang Cho
    Thyroid®.2023; 33(12): 1483.     CrossRef
  • Risks of suboptimal and excessive thyroid hormone replacement across ages
    U. Feldt-Rasmussen, G. Effraimidis, S. Bliddal, M. Klose
    Journal of Endocrinological Investigation.2023; 47(5): 1083.     CrossRef
  • Association of Mild Thyroid Dysfunction and Adverse Prognosis Among Chinese Patients With Acute ST Segment Elevation Myocardial Infarction
    Mei-Fang Li, Ze-Tao Wei, Shuai Li, Qi-Ming Feng, Jing-Bo Li
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Cardiovascular Effects of Subclinical Hyperthyroidism following Percutaneous Coronary Intervention
    Ricardo Correa, Ricardo Villela
    Clinical Thyroidology.2022; 34(6): 240.     CrossRef
  • Weight Gain and Body Composition Changes during the Transition of Thyroid Function in Patients with Graves’ Disease Undergoing Radioiodine Treatment
    Zhenqin Cai, Qiyu Chen, Yan Ling, Henrik Falhammar
    International Journal of Endocrinology.2022; 2022: 1.     CrossRef
  • Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence
    Patrick Müller, Melvin Khee-Shing Leow, Johannes W. Dietrich
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Role of thyroid hormones-induced oxidative stress on cardiovascular physiology
    María Laura Barreiro Arcos
    Biochimica et Biophysica Acta (BBA) - General Subjects.2022; 1866(12): 130239.     CrossRef
  • Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study
    Juqian Zhang, Arnaud Bisson, Grégoire Fauchier, Alexandre Bodin, Julien Herbert, Pierre Henri Ducluzeau, Gregory Y. H. Lip, Laurent Fauchier
    Journal of Clinical Medicine.2022; 11(5): 1342.     CrossRef
  • Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis
    Yu-tian Cao, Kai-yu Zhang, Jing Sun, Yan Lou, Tian-su Lv, Xinyi Yang, Wen-hui Zhang, Jiang-yi Yu, Qi-biao Wu, Xi-qiao Zhou
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Subclinical Hyperthyroidism: A Review of the Clinical Literature
    Karen Tsai, Angela M. Leung
    Endocrine Practice.2021; 27(3): 254.     CrossRef
  • Thyroid and heart, a clinically relevant relationship
    G. Corona, L. Croce, C. Sparano, L. Petrone, A. Sforza, M. Maggi, L. Chiovato, M. Rotondi
    Journal of Endocrinological Investigation.2021; 44(12): 2535.     CrossRef
  • Antithyroid Drug Treatment in Graves’ Disease
    Jae Hoon Chung
    Endocrinology and Metabolism.2021; 36(3): 491.     CrossRef
  • Cardiovascular Outcomes in Thyroid Cancer Patients Treated With Thyroidectomy: A Meta-Analysis
    Eun Kyung Lee, Hwa Young Ahn, Eu Jeong Ku, Won Sang Yoo, Young Ki Lee, Kee-Hyun Nam, Young Jun Chai, Shinje Moon, Yuh-Seog Jung
    The Journal of Clinical Endocrinology & Metabolism.2021;[Epub]     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism